drugset / Trial / NCT03456687
Effects of Exenatide on Motor Function and the Brain
Phase 1
Completed
5 enrolled
University of Florida
National Institute of Neurological Disorders and Stroke (NINDS) · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this research study is to investigate how the brain and motor behavior changes Parkinson's Disease (PD) over time in response to Exenatide. In previous clinical trials, PD patients have experienced symptomatic improvement on Exenatide and literature suggests it may help slow the progression of Parkinson's. Both will be evaluated in this study.
Timeline
- Start
- 2018-06-05
- Primary completion
- 2020-10-16
- Completion
- 2021-08-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Exenatide | Peptide | 2 mg | Subcutaneous |